 ALPHARETTA, Ga., April 06, 2022 GLOBE NEWSWIRE -- Clearside Biomedical, Inc. Nasdaq: CLSD, a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space SCS, announced today that Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will present at the Needham Virtual Healthcare Conference on Wednesday, April 13, 2022 at 3:45 p.m. ET. 